Liposomal adjuvant compositions
AssigneeZoetis Services LLC
InventorsPaul Joseph Dominowski, Duncan Mwangi, Sharath K. Rai, Dennis L. Foss, Traci K. Godbee, Laurel Mary Sly, Suman Mahan, Shaunak Vora
Life of this patent
Estimating the term…
Abstract
The invention provides a liposomal adjuvant composition comprising an external membrane and an internal compartment, the external membrane comprising: a quaternary ammonium compound; a sterol; a phospholipid; and a glycolipid. Vaccine compositions comprising the liposomal adjuvant of the instant invention are also provided.
Claims22
A liposome comprising an external lipid bilayer membrane and an internal compartment, the external membrane comprising:
- a) a quaternary ammonium compound;
- b) a sterol;
- c) a phospholipid;
- and
- d) a glycolipid of formula I:
- wherein, R1 and R2 are independently hydrogen, or a saturated alkyl radical having up to 20 carbon atoms;
- X is —CH2—, —O— or —NH—;
- R2 is hydrogen, or a saturated or unsaturated alkyl radical having up to 20 carbon atoms;
- R3, R4, and R5 are independently hydrogen, —SO42−, —PO42−, —COC1-10 alkyl;
- R6 is L-alanyl, L-alpha-aminobutyl, L-arginyl, L-asparginyl, L-aspartyl, L-cysteinyl, L-glutamyl, L-glycyl, L-histidyl, L-hydroxyprolyl, L-isoleucyl, L-leucyl, L-lysyl, L-methionyl, L-ornithinyl, L-phenyalany, L-prolyl, L-seryl, L-threonyl, L-tyrosyl, L-tryptophanyl, and L-valyl or their D-isomers.
The vaccine of claim 20, wherein the influenza virus is an inactivated Swine Influenza Virus (SIV).
Dependencies are inferred from the claim text.